Chinese Factory Linked to Drug Under Inquiry in U.S.

After the Trader Joe’s and pet food cases, now the spotlight is on Chinese drugs, from The New York Times:

A Chinese factory that has not been inspected by the Food and Drug Administration is the source for the active ingredient of a critical blood-thinning drug whose production was suspended this week after 350 patients reported ill effects from it.

At least four people died after being given the drug, .

An F.D.A. spokeswoman, Heidi Robello, said Wednesday that the agency was making plans to inspect the Chinese factory as well as a finishing plant in New Jersey “as soon as possible.”

See also “China scrutinized in blood thinner problems” from the Times.

Open popup

Welcome back!

CDT is a non-profit media site, and we need your support. Your contribution will help us provide more translations, breaking news, and other content you love.